Non-Muscle Invasive Bladder Cancer BOND-003

Last updated: August 3, 2021
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

N/A

Condition

Bladder Cancer

Treatment

N/A

Clinical Study ID

TX278992
  • Ages 18-100
  • All Genders

Study Summary

People with Non-Muscle Invasive Bladder Cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Are a male or female at least 18 years of age

  • Have pathologically confirmed CIS

  • Have received prior adequate BCG therapy

  • Are ineligible to receive radical cystectomy or refusal of radical cystectomy

  • Demonstrate adequate organ function

Exclusion

Exclusion Criteria:

  • Have received systemic anti-cancer therapy or systemic treatment, radiation therapy, or surgery for bladder cancer

  • Have significant immunodeficiency due to underlying illness or hepatitis B or C

  • Have received systemic immunosuppressive medication

  • Have had prior organ or allogenic stem cell transplant

  • Have an active infection

  • Are pregnant or breastfeeding

Study Design

Study Start date:
August 03, 2021
Estimated Completion Date:

Study Description

Connect with a study center

  • Biomedical Research Alliance of New York

    Bronx, New York 10461
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.